142 studies found for:    Open Studies | "Vomiting"
Show Display Options
Rank Status Study
1 Recruiting Study of Anesthesia Techniques to Reduce Nausea and Vomiting After Jaw Corrective Surgery
Conditions: Post-operative Nausea;   Post-operative Vomiting;   Post-discharge Nausea;   Post-discharge Vomiting
Intervention: Other: Anesthesia and postoperative medication and fluid protocol
2 Unknown  Oral Aprepitant and Lower Dose Dexamethasone Versus Aprepitant Alone for Preventing Postoperative Nausea and Vomiting (PONV) After Elective Laparoscopic Surgeries
Conditions: Nausea;   Vomiting
Interventions: Drug: Dexamethasone;   Drug: Aprepitant;   Drug: Placebo Dexamethasone
3 Unknown  Management of Nausea and Vomiting of Pregnancy
Conditions: Hyperemesis Gravidarum;   Nausea;   Vomiting;   Pregnancy
Interventions: Procedure: Day care;   Procedure: Inpatient
4 Recruiting Postoperative Vomiting in Children: Comparison Tri - Versus bi -Prophylaxis
Condition: Postoperative Vomiting
Interventions: Drug: Dexamethasone + ondansetron + Placebo;   Drug: Dexamethasone + ondansetron + Droperidol
5 Recruiting Does Acupressure Help Reduce Nausea and Vomiting in Palliative Care Patients? Formal Study
Conditions: Nausea;   Vomiting
Interventions: Device: Acupressure Wrist Bands (Sea-Bands);   Device: Placebo wristbands
6 Not yet recruiting Acupuncture for Postoperative Nausea, Vomiting and Pain in Children: The Implication of Parental Attitudes
Conditions: Postoperative Nausea and Vomiting;   Postoperative Pain
Intervention: Device: Acupuncture
7 Recruiting Does First Oral Intake After Emergence Predict the Incidence of Post-operative Vomiting in Children?
Condition: Post-operative Vomiting
Interventions: Other: Apple Juice;   Other: Water
8 Unknown  Gabapentin in the Prevention of Nausea and Vomiting Induced by Chemotherapy
Conditions: Vomiting;   Cisplatin;   Antineoplastic Combined Chemotherapy Protocols
Interventions: Drug: Placebo;   Drug: Gabapentin
9 Recruiting Effectiveness of Aprepitant in Addition to Ondansetron in the Prevention of Nausea and Vomiting Caused by Upper Abdominal Radiotherapy
Conditions: Nausea;   Vomiting
Interventions: Drug: aprepitant;   Drug: Ondansetron
10 Recruiting A Korean Study of Efficacy and Safety of Aprepitant-based Triple Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in the First Cycle of Moderately Emetogenic Chemotherapy (Non-doxorubicin Hydrochloride [Adriamycin] and Cyclophosphamide Regimens) (MK-0869-225 AM1) (KMEC)
Conditions: Nausea;   Vomiting
Interventions: Drug: Aprepitant;   Drug: Aprepitant Placebo;   Drug: Ondansetron;   Drug: Dexamethasone;   Drug: Ondansetron Placebo;   Drug: Rescue Therapy (granisetron, dolasetron, tropisetron or ondansetron; metoclopramide or alizapride).
11 Recruiting Effect of Yoga in Reducing Chemotherapy Induced Nausea and Vomiting
Conditions: Breast Cancer;   Malignant Female Reproductive System Neoplasm;   Lymphomas;   Chemotherapy-induced Nausea and Vomiting
Interventions: Behavioral: yoga;   Behavioral: Jacobsons PMRT group
12 Unknown  Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin Lymphoma
Conditions: Brain and Central Nervous System Tumors;   Childhood Germ Cell Tumor;   Extragonadal Germ Cell Tumor;   Head and Neck Cancer;   Lymphoma;   Nausea and Vomiting;   Neuroblastoma;   Ovarian Cancer;   Sarcoma
Interventions: Procedure: electroacupuncture therapy;   Procedure: management of therapy complications;   Procedure: nausea and vomiting therapy
13 Recruiting A Study to Evaluate the Safety and Efficacy of Aprepitant (MK0869) for Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients
Condition: Chemotherapy-Induced Nausea and Vomiting
Intervention:
14 Recruiting A Safety and Efficacy Study of Rolapitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Receiving Highly Emetogenic Chemotherapy
Condition: Chemotherapy-induced Nausea and Vomiting
Interventions: Drug: Rolapitant;   Drug: Granisetron;   Drug: Dexamethasone
15 Recruiting A Safety and Efficacy Study of Rolapitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Receiving Moderately Emetogenic Chemotherapy
Condition: Chemotherapy-induced Nausea and Vomiting
Interventions: Drug: Rolapitant;   Drug: Granisetron;   Drug: Dexamethasone
16 Recruiting Phase 3 Safety and Efficacy Study of Rolapitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Receiving Highly Emetogenic Chemotherapy
Condition: Chemotherapy-induced Nausea and Vomiting
Interventions: Drug: Rolapitant;   Drug: Granisetron;   Drug: dexamethasone
17 Not yet recruiting Developing Individualized Strategies to Prevent Nausea and Vomiting
Conditions: Postoperative Nausea and Vomiting;   Genetic Polymorphisms
Interventions: Drug: Ondansetron;   Drug: Lorazepam;   Drug: Aprepitant
18 Recruiting Continuous Infusion of Palonosetron for Preventing of Postoperative Nausea and Vomiting
Condition: Postoperative Nausea and Vomiting
Interventions: Drug: continuous infusion of palonosetron added to prophylactic single injection of palonosetron;   Drug: continuous infusion of normal saline added to prophylactic single injection of palonosetron
19 Unknown  B6 Treatment for Nausea and Vomiting in Pregnancy
Condition: Nausea and Vomiting Complain in Early Pregnancy
Intervention: Drug: vitamin B6
20 Recruiting Prevention of Postoperative Nausea and Vomiting in Surgical Patients
Condition: Postoperative Nausea and Vomiting
Interventions: Drug: Dronabinol;   Drug: Ondansetron

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years